Grifols

The assay runs on the Procleix Panther system and detects B. microti, B. duncani, B. divergens, and B. venatorum parasites that can be transmitted by tick bites or blood donation. 

Hologic's CEO said in December that the blood screening business was a drag on the company's growth. 

Hologic CEO Steve MacMillan said that the deal is so compelling that the firm needed to do it now.

Through their arrangement, Singulex has granted Grifols an exclusive license to its single-molecule counting technology for use in blood donor and plasma screening.

The firm's blood screening revenues received a boost from services performed for the Japanese Red Cross Society by its partner, Grifols. 

NEW YORK (GenomeWeb) — Hologic reported after the close of the market on Wednesday a 6 percent increase in revenues for its fiscal fourth quarter, including a 2 percent uptick in revenues for its Diagnostics business.

NEW YORK (GenomeWeb) – Grifols today announced the Procleix HEV assay for detection of hepatitis E has received CE marking.

NEW YORK (GenomeWeb) – Grifols has garnered a CE-IVD mark for ID Core XT, a bead array-based assay for molecular blood group typing, the company said this week.

NEW YORK (GenomeWeb News) — Grifols said today that it has been selected by the Japanese Red Cross Society as a partner in nucleic acid screening of the country's 5.3 million annual blood donations.

Pages

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.